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Abstract
Introduction: Patients with rheumatoid arthritis (RA) have disturbances in the hypothalamic-pituitary-adrenal (HPA) axis.
These are reflected in altered circadian rhythm of circulating serum cortisol, melatonin and IL-6 levels and in chronic fatigue.
We hypothesized that the molecular machinery responsible for the circadian timekeeping is perturbed in RA. The aim of this
study was to investigate the expression of circadian clock in RA.
Methods: Gene expression of thirteen clock genes was analyzed in the synovial membrane of RA and control osteoarthritis
(OA) patients. BMAL1 protein was detected using immunohistochemistry. Cell autonomous clock oscillation was started in
RA and OA synovial fibroblasts using serum shock. The effect of pro-inflammatory stimulus on clock gene expression in
synovial fibroblasts was studied using IL-6 and TNF-a.
Results: Gene expression analysis disclosed disconcerted circadian timekeeping and immunohistochemistry revealed strong
cytoplasmic localization of BMAL1 in RA patients. Perturbed circadian timekeeping is at least in part inflammation
independent and cell autonomous, because RA synovial fibroblasts display altered circadian expression of several clock
components, and perturbed circadian production of IL-6 and IL-1b after clock resetting. However, inflammatory stimulus
disturbs the rhythm in cultured fibroblasts. Throughout the experiments ARNTL2 and NPAS2 appeared to be the most
affected clock genes in human immune-inflammatory conditions.
Conclusion: We conclude that the molecular machinery controlling the circadian rhythm is disturbed in RA patients.
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Introduction
Endogenous circadian rhythm is maintained by the central
circadian timekeeper, the suprachiasmatic nuclei of the hypothal-
amus. The clock machinery is composed of heterodimeric
transcription factors and transcription regulatory proteins. The
expression of these factors oscillates rhythmically over 24-hour
cycles [1–3]. The rhythm of the central master clock is transferred
to cells in the peripheral organs through hormonal and neuronal
connections [2,4]. The de-synchronization of endogenous and
geophysical time leads to fatigue as in jet lag. Altered circadian
rhythm can cause e.g., cancer and obesity [5,6].
The molecular core of the circadian machinery is composed
of transcription factors Aryl hydrocarbon Receptor Nuclear
Translocator-Like (ARNTL/BMAL1) and Circadian Locomotor
Output Cycles Kaput (CLOCK), which heterodimerize and
activate transcription from E-box elements located in the
promoters of clock controlled genes. Their paralogs ARNTL2
(BMAL2) and Neuronal PAS domain-containing protein 2
(NPAS2), respectively, may functionally replace them. These
transcription factors drive the expression of clock output genes,
for example albumin D-box binding protein (DBP) but also their
own repressors cryptochrome (CRY1, CRY2) and period (PER1,
PER2 and PER3) proteins. CRY and PER proteins form
heterodimers and translocate to nucleus, in which they inhibit
the function of DNA bound BMAL1:CLOCK heterodimer.
Thus, CRY and PER proteins inhibit their own expression but
also the expression of other clock controlled genes composing a
negative regulatory limb of the circadian clock. RAR-related
Orphan Receptor proteins RORs and REV-ERBs effect on the
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e54049
positive limb of circadian machinery. RORs bind into the
promoter region and drive the expression of BMAL1. By
competing of this binding site REV-ERBs inhibit ROR activity.
This network of feedback loops affecting on the positive and
negative sites around the core drives the usually extremely
accurate self-sustained rhythmic expression of the circadian
clock genes. Basic helix–loop–helix (bHLH) transcription factors
BHLHE40 (DEC1) and BHLHE41 (DEC2) directly inhibit
BMAL1:CLOCK by competing in binding of E-box elements
in DNA. Thus, they form still another layer of the control
mechanisms. This complex system of transcriptional regulation
forms the molecular clockwork of the circadian timekeeper and
creates the rhythmic expression of its output genes [1,2,4].
Rheumatoid arthritis (RA; MIM 180300) is a chronic inflam-
matory joint disease, a progressive destructive and debilitating
arthritis caused by an invasive infiltrate composed of inflammatory
cells and synoviocytes. Patients suffering from RA as well as other
autoimmune diseases display blunted hypothalamic-pituitary-
adrenal (HPA) axis reactions to inflammation [7], altered rhythm
of circulating cortisol, melatonin and IL-6 levels [8,9]. Remark-
ably, up to 80% of patients experience chronic fatigue [10,11].
The function of T- and B-cells is perturbed in RA. This is seen
e.g., in autoantibody production and in the fact that therapeutic
targeting of either T- or B-cells is an effective treatment for RA.
Interestingly, the same molecules that function in the intact clock
controlling circadian rhythm e.g., rhythmic cortisol production
[12] also control the development and function of immune cells.
For example, Dec1 deficient animals develop systemic autoimmu-
nity [13], Dec2 affects the development of Th2 cells [14], Rorc the
development of Th17 cells [15] and Rora is a negative regulator of
NF-kB signaling pathway [16].
It also appears that there are bidirectional links between the
circadian time keeping and TNF-a production. For example,
Cry1/Cry2 deficiency in mice affects TNF-a production and
exacerbates arthritis [17]. Conversely, TNF-a can alter the
expression of clock genes and inflammation modifies the
endogenous rhythm [18,19].
Because RA patients suffer from chronic fatigue, have
immune cell dysfunction, and pathogenic production of TNF-
a, all of which are affected by the molecular clock, we
hypothesized that the circadian timekeeping is perturbed in RA.
Thus, we analyzed the function of the circadian clock in RA
patients and compared that to the function of clock in
osteoarthritis (OA) patients, who have cartilage deterioration
without autoimmunity and chronic fatigue. By doing so, we
revealed clearly abnormal molecular clockwork in the synovial
membrane tissue of the patients as well as in the cells derived
from the synovial membrane.
Methods
Subjects
The research plan was approved by the ethical committee of the
Helsinki University Central Hospital. Guidelines of the Declara-
tion of Helsinki were followed. RA patients fulfilled the 1987
revised criteria of the American College of Rheumatology. Tissue
samples (n = 10 for both RA and OA patients) were taken at 10
a.m. 62 h during synovectomy or operation for total joint
replacement. Samples were divided so that one half was formalin
fixed and embedded in paraffin and the other half was
immediately snap-frozen in isopentane precooled by dry ice and
stored at 270uC.
Immunohistochemistry
Serial 3 mm thick paraffin tissue sections from the formalin
fixed synovial membrane samples were stained using Bond
MaX fully automated IHC and ISH Staining System (Leica
Microsystems) using programs and Bond reagents for Dewax
solution for deparaffinization, Epitope Retrieval solution 1 for
antigen retrieval and Bond Polymer Refine kit for antigen
detection. Briefly, slides were deparaffinised followed by one
wash in absolute ethanol. Antigens were retrieved following
endogenous peroxidase quenching. Sections were incubated in
1 mg/ml rabbit anti-MOP3 (anti-Bmal1; AB4140, Chemicon).
Rabbit IgG at the same concentration was used for negative
staining control. After secondary antibody containing the HRP
polymer, color was developed using H2O2 and DAB. Between
each step slides were washed at least three times. Finally, slides
were dehydrated, cleared and coverslips were mounted using
Mountex (Histolab).
RNA Isolation, cDNA Synthesis and Quantitative Real-
time PCR
RNA was isolated using RNeasy Mini Kit according to the
manufacturer’s instructions. RNA concentrations were measured
using NanoDrop ND-1000 instrument (Thermo Fisher Scientific).
The cDNA synthesis was performed using 500 ng of total RNA
and iScriptTMcDNA Synthesis Kit (Bio-Rad) in a 20 ml reaction
volume. Quantitative real-time PCR was performed from 1:5
diluted cDNA in iQTM SYBRH Green Supermix (Bio-Rad) using
gene specific primers (Table 1) in 20 ml reaction volume. The PCR
was performed in iQ5 real-time PCR detection system (Bio-Rad).
Cell Culture
Synovial fibroblasts from RA (n= 3) and OA (n= 3) patients
were established using explant culture method. Tissue samples
were cut into pieces with a sterile scalpel in a laminar flow hood.
The explants were left overnight in RPMI-1640 medium (Lonza)
containing 10% fetal bovine serum (Lonza) with 1000 U/ml
penicillin and 0.1 mg/ml streptomycin (106) solution. The next
day, the media were changed to basal RPMI with 10% FBS media
and 100 U penicillin and 0.1 mg streptomycin (16 solution). The
medium was changed twice a week for 3 weeks. After roughly 80%
monolayer confluence was reached, the explants were removed,
and the cells were subcultured 1:3 until confluent. Passages 2–4
were used for subsequent experiments.
Clock Resetting with Serum Shock
The clock resetting in RA and OA fibroblasts was performed as
reported earlier [20]. Briefly, cells were cultured in RPMI
including supplements until ready for the serum shock. For the
serum shock 150 000 cells were plated on 6-well plates. The cells
were grown to confluence. At TIME= -2, the medium was
replaced to RPMI containing penicillin/streptomycin and 50%
horse serum (GIBCO). Samples to determine baseline were also
collected at this point. After 2 hours, the medium was replaced
with serum-free RPMI containing the antibiotics (TIME=0).
Exactly at the indicated times, the wells were washed with PBS
and lyzed with 350 ml RLT lysis buffer (Qiagen). The lysates were
stored at 270uC until RNA isolation was performed.
TNF-a and IL-6 Stimulation
OA fibroblasts were cultured in RPMI including supplements
until ready for the stimulations. For the stimulations 80 000
cells were plated on 12-well plates. The cells were grown to
confluence. Before stimulations the cells were synchronized with
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18 hours serum starvation using RPMI containing penicillin/
streptomycin and 1% fetal bovine serum. At TIME=0, the
media were replaced with RPMI media containing penicillin/
streptomycin, 1% fetal bovine serum and TNF-a (10 ng/ml;
R&D Systems), IL-6 (10 ng/ml; R&D Systems) or no cytokines
(negative control). At the indicated times, the wells were washed
with PBS and lyzed with 350 ml RLT lysis buffer (Qiagen). The
lysates were stored at 270uC until RNA isolation was
performed.
Statistical Analysis
The data from tissues were analyzed using Student’s t-test and
Pearson correlation test with SPSS 15.0 for Windows. The data
from clock reset experiment were fitted to a sine wave equation,
y(x) =BaseLine+Amplitude sin (frequency x+PhaseShift) in Matlab
(The MathWorks Inc., Natick, MA, USA). The frequency was
fixed to 24 hours. From IL-1b, IL-6 and Per1, the first time point
(TIME=0) was excluded from the fit, to avoid errors generated by
the initial high expression peak caused by the stimulus. A Student’s
t-test was applied to determine, whether or not the phase, baseline
(general expression level) or amplitude (peak expression) was
shifted between RA and OA samples.
Results
Clock Gene Expression is Disturbed in RA Synovium
Driven by our hypothesis that the circadian timekeeping is
perturbed in RA, we analyzed expression levels of clock genes in
the synovial membrane of RA patients in comparison to OA
patients. The expression levels of BHLHE40 and NR1D1 (REV-
ERBa) were significantly increased in RA synovium compared to
OA synovium (Figure 1a).
To overcome the variation of sampling time between
individuals we reasoned that the best indication of the subjective
(endogenous) time would be the correlation of the expression of
BMAL1 and PER1, which are normally in antiphase against
each other. Due to the negative feedback loop, the peak
expression of BMAL1 and PER1 should definitely not occur at
the same time. Indeed, this was true in the control synovial
membranes obtained from OA patients: high BMAL1 expression
coexisted with low PER1 expression and vice versa (Figure 1). RA
patients, in contrast, did not have this kind of anti-phase
BMAL1 and PER1 expression (Figure 1). Similarly, high
ARNTL2 and NPAS2 expression occurred simultaneously with
the inhibitory clock components only in RA. Most striking was
the significant positive correlation of NPAS2 and PER1
expression in RA (Figure 1), while it as expected was
significantly negative in OA (Figure 1). Further, ARNTL2
expression correlated positively with the expression of CRY1
(.715; p,0.05), CRY2 (.951; p,0.001), PER2 (.862; p,0.01),
BHLHE40 (.936; p,0.001) and BHLHE41 (.785; p,0.01) only
in RA.
Ectopic Sub-cellular BMAL1 Protein Localization in RA
Synovium
After revealing that the expression of clock genes is disturbed in
the RA patients, we sought for confirmation to this observation on
the protein level. We used immunohistochemistry to localize the
limiting core clock component BMAL1 in the synovial tissues of
RA and OA patients. The intense cytoplasmic BMAL1 protein
staining in RA tissues draws attention to another major aberration.
Not only are the phases of ARNTLs and NPAS2 relative to CRYs
Table 1. Primers.
Gene GeneBank Accession 59 Primer 39 Primer Length
BMAL1 NM_001178 CTGGAGAAGGTGGCCCAAAGAG CCACTGGAAGGAATGTCTGGAGTC 250
ARNTL2 NM_020183 GCTAGAGGCTACCAGGCAAAACC GGTCCACTGGATGTCACTGAAGTC 193
CLOCK NM_004898 TTCTGCCTCTTCTCGGAGTTCAAG CCTGGGTGGAGTGCTCGTATC 103
NPAS2 NM_002518 CTTCCCTGCCTCCCAACCATC GGTCCCTGGCTGTTGTGAGTAG 151
BHLHE40 NM_003670 TCAGCAGCAGCAGAAAATCATTGC GTGGGTGACAAGCTGCGAAGAC 187
BHLHE41 NM_030762 TGCTTTACAGAATGGGGAGCGATC CCCTGGGTGTCCAGCTCTCAAAC 134
PER1 NM_002616 CTCCAATCAGGACGCACTTTC GCTGCCAAAGTATTTGCTTGTG 211
PER2 NM_022817 TGTAGGGGCGGACTGCAAAC TGCTGGTATGACTTGTGTCACTAC 251
PER3 NM_016831 TGAAGAATCCATCCCATCCTACTG TATACTGCTGTCGCTGCTTCC 218
CRY1 NM_004075 TCTGGCATCAGTACCTTCTAATCC CTGTGTGTCCTCTTCCTGACTAG 226
CRY2 NM_021117 GGTGAAGAACTCAGCAAACGG ACACACATGCTCGCTCTATCTC 189
RORA NM_134262.2 CCAGCCCCGACGTCTTCAAAT GCCATGAGCGATCTGCTGACA 150
RORB NM_006914.3 ACCGTTGCCAACACTGCCGA GCTGGTGCTTCTGCACCTCA 126
RORC NM_001001523.1 GGGCTGCAGCGAGCTCATCA TCTCTTGGAGCCCTGGCCGA 134
NR1D1 NM_021724 CTTGGCTGCCCAGCGTCATAAC CCAGATCTCCTGCACCGTTCG 274
DBP NM_001352 CTTAAGCCCCAGCCAATCATGAAG CCGCCCGCACCGATATCTG 160
IL-1b NM_000576 TGGCAATGAGGATGACTTGT GGAAAGAAGGTGCTCAGGTC 237
IL-6 NM_000600.3 AGGAGACTTGCCTGGTGAAA GAGGTGCCCATGCTACATTT 329
b-act NM_001101.3 TCACCCACACTGTGCCCATCTACGA CAGCGGAACCGCTCATTGCCAATGG 295
PBGD NM_000190.3 ACATGCCCTGGAGAAGAATG AGATGCGGGAACTTTCTCTG 237
RPLP0 NM_001002 GGCGACCTGGAAGTCCAACT CCATCAGCACCACAGCCTTC 149
doi:10.1371/journal.pone.0054049.t001
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Figure 1. The expression of circadian genes in RA and OA patients. A. Synovial membrane samples were collected from RA and OA patients
(n = 10 for each) and analyzed for circadian gene expression. The relative expression of each gene is expressed as mean 6 SD. B. The expression of
BMAL1 and PER1 should be in anti-phase. Pearson correlation and the linear fit for the expression of BMAL1 and PER1 in the synovial membrane of RA
patients reveals that high expression of BMAL1 correlates with high PER1 expression and vice versa, low BMAL1 expression correlates with low PER1
expression. In contrast to synovium of RA patients, the high expression of BMAL1 was associated with low PER1 expression and conversely, low BMAL1
Circadian Timekeeping in Rheumatoid Arthritis
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expression was coupled with high PER1 expression in the synovial membrane of OA patients. Similar findings were observed with NPAS2 and PER1 as
well as with ARNTL2 and CRY2. Each dot indicates the Ct value of BMAL1, NPAS2 or ARNTL2 in the x-axis and PER1 or CRY2 in the y-axis in the synovial
membrane sample of an individual patient. *p,0.05.
doi:10.1371/journal.pone.0054049.g001
Figure 2. Localization of BMAL1 protein in RA and OA synovium. Tissue sections were incubated in rabbit anti-BMAL1 (anti-MOP3). In RA (A
and B), relatively strong immunoreactivity was detected in the nuclei (arrows) of the immune cells and fibroblasts, but even stronger
immunoreactivity was observed in the cytoplasm of the cells (arrowheads). In contrast to RA, BMAL1 protein was localized only in the nuclei (arrows)
of OA synovium (C and D). Irrelevant rabbit IgG was used to confirm the specificity of the BMAL1 antibody (E and F). Scale bar 100 mm.
doi:10.1371/journal.pone.0054049.g002
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and PERs disturbed in RA, but this is also accompanied by ectopic
localization of a core clock component (Figure 2).
Cell Autonomous Defect of Clock Function in RA
To rule out the possibility that inflammation, medication or
some endocrine factors in the patients is the reason for the
perturbed expression of circadian genes in RA synovium, we
induced clock resetting with serum [20] in synovial fibroblasts
isolated from RA and OA tissue samples. Immediately after
resetting the expression pattern of BMAL1 was delayed 0.5 hours
(p = 0.05) in RA fibroblasts compared to OA fibroblasts, i.e. the
expression of BMAL1 in RA cells peaked 30 minutes later that OA
cells. In addition to this, the expression level of BMAL1 in RA cells
never reached the level of OA (p= 0.05). The expression peak of
ARNTL2 was delayed 1.1 hours (p,0.05) and the level was
throughout the experiment significantly lower (p,0.05) in RA cells
compared to OA cells. Similarly, CLOCK expression was delayed
1.4 hours (p,0.05) in RA fibroblasts and the relative expression
was constantly lower (p,0.05) in RA cells and NPAS2 expression
was delayed 1.9 hours (p = 0.05) but was constantly higher in RA
fibroblast (p = 0.01) than in OA fibroblasts. Based on the delayed
expression of the core clock, one would expect that the expression
of clock driven circadian genes would lag in RA cells compared to
OA cells. In contrast, the expression of PER1 increased 0.5 hours
earlier (p = 0.05), and the expression of CRY2 was constantly
higher in RA than OA cells after serum shock. Also CRY1
expression increased earlier in RA cells than in OA cells,
indicating that expression of the negative feedback loop is
activated faster in RA than in OA. On the positive limb of the
circadian machinery, RORA expression was 1.2 hours (p,0.05)
ahead and constantly higher (p = 0.01) in RA cells than in OA
cells, and NR1D1 expression was exactly the same in both cell
types (Figure 3). RORB and RORC were not expressed.
Altered Circadian IL-1b and IL-6 Expression in RA
Fibroblasts
RA patients display altered circadian hormonal and cytokine
profiles. For example, the circulating concentration of IL-6 in RA
patients differs from that of healthy individuals [8]. We tested the
possibility that the perturbed clock function is also reflected in
disturbed IL-6 expression after clock resetting. Fibroblasts derived
from RA displayed significantly weaker rhythmic expression of IL-
6 after clock resetting than cells from OA synovium (Figure 4).
Both the general expression as well as the peak expression was
higher in OA cells (p,0.05 for both). Because of this observation,
we analyzed if this is the case also for IL-1b or TNF-a expression,
which are also rhythmically produced pro-inflammatory cytokines
[21,22]. Similar to IL-6 expression, RA fibroblasts displayed
significantly weaker rhythmic expression of IL-1b than OA
fibroblasts (p,0.05) Also TNF-a expression was rhythmic over
time. In contrast to the expression of IL-1b and IL-6, the general
expression level of TNF-a was higher (p = 0.05) in RA cells than in
OA cells. Like in the expression of IL-1b, both the phase (p,0.05)
and the amplitude (p,0.05) in TNF-a expression were different
between the cells derived from RA and OA synovium (Figure 4)
confirming the near absent and misaligned self-sustained rhythmic
expression of pro-inflammatory cytokines in RA cells.
Inflammation Changes the Expression of Clock Genes In
Vitro
Due to the bidirectionally maintained control of clock and
inflammation, we investigated the effect TNF-a on human
fibroblasts. A strong response in the expression of IL-1b
(Figure 5) was evident confirming the effect of TNF-a on the
cells. The most significantly affected clock genes after stimulation
with TNF-a were ARNTL2 and NPAS2. Unlike earlier observa-
tions in mouse cells [18], TNF-a did not affect the expression of
PER1. However, the inhibitory (anti-phase) effect of TNF-a on the
expression of clock controlled genes DBP and PER3 was clear
(Figure 5). IL-6 did not markedly alter the expression of clock
genes.
Discussion
Abnormal fatigue, morning stiffness and altered circadian
hormone and cytokine production suggest that the internal
neuroimmunoendocrine milieu and the activity of daily living
may be desynchronized in RA patients [7,8,10] i.e., the body is
adjusted for activity (subjective day) during sleep (geophysical
night), but meets the challenges of the day when geared for sleep
and rest. Central molecular clock in the hypothalamus normally
synchronizes body functions and entrains the circadian clocks in
all cells of the peripheral tissues [2,4]. According to our findings
the clock is dysfunctional in the joints of RA patients. Our results
suggest that inflammation may initially disturb circadian time-
keeping and that a cell autonomous defect prevents accurate clock
function in the synovial fibroblasts of RA patients.
The variation in the expression of circadian genes at a defined
and very narrow time point used for sample collection was evident
between different individuals. Due to the characteristic oscillation
of the expression of clock genes [1–3] leading to individual
sleeping habits of each subject this was expected. To overcome the
problem, we utilized the characteristic property of the clock and
analyzed the endogenous (subjective) time using the expected anti-
phase expression of inhibitory circadian genes in RA synovium
and in OA synovium, i.e. checked the circadian time. This anti-
phase expression of inhibitory circadian components, which forms
the very basis for the circadian timekeeping, was totally lost in RA
synovium i.e., the endogenous circadian time is clearly perturbed
in the synovial membrane tissue of RA patients.
The perturbed expression of the machinery is also reflected in
the amount and sub-cellular localization of BMAL1 protein.
Apparently, there is much higher levels of BMAL1 protein in RA
than OA while at RNA levels the difference is not significant. Of
the core clock genes the expression of BMAL1 varies the most
during the day. Due to this oscillation of the expression, however,
we may have not detected the highest differences in the gene
expression. The most dramatic differences in the gene expression
may well be seen at different time points whereas the amount of
protein in the tissue may reflect the differences in the expression or
different kinetics in the posttranslational mechanisms that regulate
the degradation of the core clock proteins [23,24]. This may well
explain why the gene expression and protein amounts do not
correlate. However, the result reinforces the finding of a disturbed
clock in RA tissue.
RA patients suffer from chronic inflammation and altered
glucocorticoid signaling, both of which affect the circadian
timekeeping effectively [18,25]. Thus, these factors or medication
might explain altered clock gene expression in the synovium of RA
patients. This possibility was excluded using cultured synovial
fibroblast derived from RA and OA patients. Clock gene
oscillation in fibroblasts can be started with serum, which activates
several intracellular pathways. Due to the intrinsic character of the
clock the cells maintain the rhythm several days without any
external time cues and further activation of the signaling pathways
[20]. This phenomenon thus reflects the normal function of the
endogenous timekeeping molecular machinery. Using this system
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Figure 3. Relative clock gene expression over time after serum shocked primary fibroblasts. Fitted sin graphs of the expression and
mean6 SD of the mean from three individual patients per group are shown. The time of serum removal is 0 in the graphs and the relative expression
is normalized to the expression before serum (at time=22). Db indicates the general difference in the expression i.e., the baseline of the expression.
Phase differences are marked as red solid lines and the difference is indicated in hours.
doi:10.1371/journal.pone.0054049.g003
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we observed near two-hour phase differences between RA and OA
in the circadian gene expression already short after clock resetting.
This is remarkable, because normally the self-sustained rhythm
varies only 0.32 hours per day [26] and patients from whom these
fibroblasts were isolated were randomly selected i.e., they were not
selected by chronotype or any other factor that may impact the
results. Thus, our results most likely reflect true differences
between RA and OA patients. Importantly, the expression of
PER1, for example, increased equally in RA and OA cells
immediately after clock resetting, but the self-sustained rhythm
was divergent. This excludes the effect of the initial serum shock,
inflammation or other endocrine factors as the sole reasons for the
disturbed clock gene expression in RA synovium and underlines a
primary, cell autonomous defect in the control of the biorhythm in
RA, i.e. a defect in the circadian clockwork itself.
Because RORs drive the expression of BMAL1 [27,28], lag of
BMAL1 expression suggests delayed or diminished expression of
ROR genes or a low ratio between the expression of ROR genes
and their competitor REV-ERBa in RA cells. However, early and
increased RORA expression in RA cells and equal REV-ERBa
expression in RA and OA cells exclude this possibility. The
expression of ARNTL2 and NPAS2 were also different in RA and
OA. This is particularly important based on the fact that ARNTL2
and NPAS2, not PER1, react to inflammation in human fibroblasts
and some mouse tissues (data not shown).
RA patients have HPA-axis dysfunction in response to
inflammation [7,8]. Due to the bidirectional links between
inflammation and clock, we wanted to investigate the effect of
inflammation on clock gene expression. IL-6 did not affect
significantly the expression of clock genes. Thus, the purpose of
robust oscillation of IL-6 levels in the blood most likely is not to
synchronize peripheral clocks. However, TNF-a affected clock
gene expression in the cultured synovial fibroblasts, indicating that
inflammation can disturb normal circadian rhythm rapidly in the
peripheral tissues.
Accurate circadian clock allows orchestrated proactive rather
than reactive bodily functions. The data presented here clearly
show that RA patients have a deficiency in the function of the
clock. It must be emphasized that it is not the synovium or synovial
fibroblasts that may cause these disturbances. Rather this cell
autonomous phenomenon reflects the behavior of all molecular
clocks in the body including the central clock, because circadian
clock has virtually the same molecular makeup in the central
timekeeper and different peripheral cells [29]. Based on this, our
in vitro results suggest that RA patients, despite obtaining resetting
stimuli every day, tend to lose the rhythm relatively fast due to a
cell autonomous defect in their circadian clock. This may explain
why the patients experience the fatigue as if they would be in a
constant jet lag. The clock not only controls the circadian rhythm
but also affects the development and function of immune cells.
Thus, the immunological, neuronal and endocrine problems
observed in the RA patients may be caused by cell autonomous
dysfunction of the clock. This is further reinforced by the fact that
novel biotherapies (anti-TNF, anti-B cell, anti T-cell, or anti-IL-6)
have only limited impact on chronic fatigue in RA [30] at least
partly excluding the possibility that inflammatory factors directly
cause this severe problem in RA. Notably, ARNTL2 and NPAS2
are the clock genes that throughout different experiments were the
most disturbed.
Conclusion
Herein, we show that RA patients display cell autonomous
disconcerted circadian timekeeping. Throughout the analysis
ARNTL2 and NPAS2 were the genes revealed to be most associated
with human inflammatory conditions. Strikingly, PER1 did not
react to inflammatory stimulation in human fibroblasts. It appears
that RA patients may experience the fatigue as if they would be in
constant jet lag. Thus, chronotherapy that takes this altered
Figure 4. The oscillation of IL-1b, IL-6 and TNF-a in RA and OA
cells after serum shock. Relative gene expression over time is
displayed. Fibroblasts derived from RA synovium display weaker
rhythmic expression of IL-1b, IL-6 and TNF-a after clock resetting than
cells from OA synovium. Fitted sin graphs of the expression and mean
6 SD of the mean from three individual patients per group is shown.
The time of serum removal is 0 in the graphs and the relative expression
is normalized to the expression before serum (at time=22). Db
indicates the general difference in the expression i.e., the baseline of
the expression. DA indicates the differences in the peak amplitude.
Phase differences are marked as red solid lines and the difference is
indicated in hours.
doi:10.1371/journal.pone.0054049.g004
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rhythm into account and/or tries to correct it could be beneficial
for the patients.
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Figure 5. TNF-a increased ARNTL2 and NPAS2, and suppresses PER3 and DBP expression but IL-6 did not. Relative gene expression over
time is displayed. Representative data from one experiment is shown. The experiment was repeated five times using fibroblasts from different OA
patients. The time of TNF-a or IL-6 addition is 0 in the graphs.
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